Abstract
Purpose
In placentae from uneventful pregnancies a direct relationship between expression of tissue factor (TF) and tissue-factor pathway inhibitor type 2 (TFPI2) was found, as well as between TF and vascular endothelial growth factor (VEGF). Furthermore, placentae from gestational vascular complications (GVCs) lack these correlations. Aims of the present study are (1) to evaluate a possible role of low-molecular-weight-heparins (LMWHs) in the modulation of the expression of TF, TFPI, TFPI2 and VEGF in placentae from thrombophilic women and (2) to study the possible role of endothelium in the placental expression of markers involved in haemostasis and angiogenesis.
Methods
Fourteen pregnancies in thrombophilic women and 11 uneventful pregnancies in non-thrombophilic women were studied and placentae collected. From each placenta total RNA was obtained. Expression of TF, TFPI, TFPI2 and VEGF was evaluated. Human Vein Endothelial Cells were incubated with increasing doses of LMWH and expression of TF, TFPI and VEGF was measured.
Results
Expression of all the markers analyzed in placentae from treated pregnancies was similar to that observed in placentae from uneventful ones. A significant direct relationship between TF and TFPI2, as well as TF and VEGF, was observed in cases treated with LMWHs and controls. Furthermore, the expression of TF and its inhibitors and VEGF in endothelial cells was modulated by LMWH.
Conclusion
Present data suggest that LMWH during pregnancy in thrombophilic women restores the relationship between markers of haemostasis and angiogenesis. Furthermore, the endothelium is likely to play an important role in this phenomenon.
Similar content being viewed by others
References
Erlich J, Parry GCN, Fearns C et al (1999) Tissue factor is required for uterine haemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci 96:8138–8143
Abe K, Shoji M, Chen J et al (1999) Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci 96:8663–8668
Parry GC, Mackman N (2000) Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. J Clin Invest 105:1547–1554
Aharon A, Brenner B, Katz T, Miyagi Y, Lanir N (2004) Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental haemostasis. Thromb Haemost 92:776–786
Wulff C, Wilson H, Dickson SE, Wiegand SJ, Fraser HM (2002) Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66:802–812
Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160:1405–1423
Kaufmann P, Black S, Huppertz B (2003) Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69:1–7
Saito T, Takeda N, Amiya E, Nakao T, Abe H, Semba H, Soma K, Koyama K, Hosoya Y, Imai Y, Isagawa T, Watanabe M, Manabe I, Komuro I, Nagai R, Maemura K (2013) VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing. FEBS Lett 587(14):2179–2185. doi:10.1016/j.febslet.2013.05.038
Fan X, Rai A, Kambham N, Sung JF, Singh N, Petitt M, Dhal S, Agrawal R, Sutton RE, Druzin ML, Gambhir SS, Ambati BK, Cross JC, Nayak NR (2014) Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest. 124(11):4941–4952. doi:10.1172/JCI76864
Chinni E, Colaizzo D, Margaglione M et al (2008) Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta. Thromb Res 122:376–382. doi:10.1016/j.thromres.2007.12.016
Chinni E, Colaizzo D, Tiscia GL et al (2010) Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: impairment of mechanisms involved in maintaining intervillous blood flow. Thromb Res 125:267–271. doi:10.1016/j.thromres.2009.09.024
Grandone E, Tomaiuolo M, Colaizzo D, Ames PR, Margaglione M (2009) Role of thrombophilia in adverse obstetric outcomes and their prevention using antithrombotic therapy. Semin Thromb Hemost 35(7):630–643. doi:10.1055/s-0029-1242717
Kupferminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, Eldor A (2001) Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia. Hypert Pregn 20:35–44
Ceccarelli M, Bani D, Cinci L, Nistri S, Uliva C, Ragazzo E, Vannacci A, Manoni M, Gori AM, Abbate R, Gensini GF, Masini E (2009) Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy. J Cell Mol Med 13:2704–2712. doi:10.1111/j.1582-4934.2009.00658.x
Practice Committee of the American Society for Reproductive Medicine (2008) Definitions of infertility and recurrent pregnancy loss. Fertil Steril 89:1603
Parazzini F, Cortinovis I, Bortolus R, Fedele L, Recarli A (1995) Weight at birth by gestational age in Italy. Hum Reprod 10:1862–1863
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 25:402–408
Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745–2756
Paidas M, Ku DH, Triche E, Lockwood C, Arkel Y (2004) Does heparin therapy improve pregnancy outcome in patients with thrombophilias? J Thromb Haemost 2:1194–1195
Urban G, Vergani P, Tironi R, Ceruti P, Vertemati E, Sala F, Pogliani E, Triche EW, Lockwood CJ, Paidas MJ (2007) Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. Int J Fertil Womens Med 52:59–67
Grandone E, De Stefano V, Rossi E, Cappucci F, Colaizzo D, Margaglione M (2008) Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis 19:226–230. doi:10.1097/MBC.0b013e3282f54545
Shen BQ, Lee DY, Cortopassi KM, Damico LA, Zioncheck TF (2001) Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells. J Biol Chem 276:5281–5286
Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing T (2011) Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124(8):940–950. doi:10.1161/CIRCULATIONAHA.111.034793
Acknowledgments
We thank Dr. E. Mangiullo for collecting samples.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Grandone, E., Chinni, E., Villani, M. et al. Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins. Arch Gynecol Obstet 294, 1323–1329 (2016). https://doi.org/10.1007/s00404-016-4185-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-016-4185-8